GLP-1 Equivalent: What Actually Matches It in the UK (October 2026)

01 · The core answer

The short answer: nothing natural matches it

No natural product, supplement or food is a clinical equivalent to a prescription GLP-1 medicine. Your body does make GLP-1, a gut hormone released after eating, but you cannot raise it to a medicinal level by eating a particular food or taking a capsule. Prescription treatments are designed, tested and licensed to act on the same receptors at a reliable strength.

Some want a cheaper product that does the same job. Some want a natural route because injections feel daunting. Others hold a prescription for one medicine and want to know what sits alongside it.

02 · Sorting the options

What genuinely counts as an equivalent

The only real equivalents are other licensed medicines that act on the GLP-1 receptor. Semaglutide, sold as Wegovy for weight management, is a once-weekly injection.¹⁸ Liraglutide, supplied at a concentration of 6mg/ml, is a daily injection, unlike once-weekly Mounjaro and Wegovy. Tirzepatide, sold as Mounjaro, is a once-weekly injectable prescription medicine made by Eli Lilly.¹

Each is a different molecule with its own dose ladder and its own licence. They are not interchangeable milligram for milligram, which is why a prescriber, not a conversion chart, decides how to move between them. Our guide to GLP-1 agonist equivalent doses explains why dose comparisons across products mislead.

03 · What to do next

What to do next if you want a real option

If you want treatment that is actually comparable, the route is a consultation with a prescriber. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.¹ Individual results vary.

Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. You can see current strengths and prices on the Mounjaro pen page, where all six doses are in stock. For wider context on how we approach treatment, see our weight loss clinic page.

Nothing here is a reason to start or stop anything without speaking to a prescriber.

04 · What GLP-1 is

What GLP-1 is and what "equivalent" really means

GLP-1 is a natural gut hormone, and an equivalent has to act on the same receptor at a dependable strength. That second part is what rules out almost everything sold online as a stand-in. A hormone-like effect that is faint, variable or unproven is not equivalent to a medicine that has been through formal trials and licensing.

Tirzepatide shows how the medicines work in practice. It activates GIP and GLP-1 receptors, two natural gut-hormone targets. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

The word "equivalent" gets used loosely in three different ways. A pharmacological equivalent is another medicine acting on the same receptor. A dose equivalent is an attempt to compare strengths across different products, which is not straightforward because the molecules differ. A natural equivalent is a food or supplement said to mimic the effect, and this last category has no clinical standing.

It helps to separate the hormone from the drug. The hormone your body releases is short-lived and tightly regulated. Licensed medicines are engineered so that they stay active long enough to be taken weekly, or daily in the case of liraglutide. That engineering is the whole point, and it cannot be replicated by eating differently or taking a capsule.

This is also why the question "how can I get GLP-1 naturally?" has a limited answer. Eating regular meals, with protein and fibre, supports your body's own signalling in the ordinary way. It does not deliver a treatment-level effect, and anyone who tells you it does is selling something. Our related guide on a natural equivalent to Mounjaro covers the same ground for tirzepatide specifically.

A practical test is to ask four questions of any product described as an equivalent. Is it a licensed medicine? Was it tested in a named trial for weight management? Does a prescriber review you before you take it? Is the dose standardised and on the label? If the answer to any is no, it is not an equivalent in any clinical sense, whatever the marketing says.

That framing matters because it protects you. A product that fails those four tests may be harmless, or it may be wasted money, or it may carry risks nobody has measured. Without oversight there is nobody to tell you which. Prescription treatment, by contrast, comes with a review of your health, follow-up and a route to report side effects through the Yellow Card scheme.¹⁹

05 · Prescription GLP-1 medicines

The prescription medicines in the GLP-1 family

There are three licensed injectable families you are likely to meet in the UK, and each suits different people. Understanding them answers the question "what can I take instead of GLP-1?" because the honest answer is usually a different GLP-1 medicine, chosen with a prescriber.

Semaglutide is sold as Wegovy for weight management. Wegovy pens come in 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg strengths, taken once weekly. Titration steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17, and 2.4mg is the licensed maintenance dose for weight management.¹⁸ You can read about it on our Wegovy pen page, where first-order pricing is shown live.

Liraglutide is a different molecule, supplied at a concentration of 6mg per millilitre. It is a daily injection, unlike once-weekly Mounjaro and Wegovy. Some people find a daily routine easy to remember, while others prefer a weekly pen. That preference is a legitimate part of the decision, though your prescriber will weigh suitability too.

Tirzepatide is Mounjaro. It is licensed in the UK for weight management in adults and for type 2 diabetes, and comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ It is the only one of the three that acts on both GIP and GLP-1 receptors.

Tablet options now exist too. Wegovy tablets contain oral semaglutide, and Foundayo contains orforglipron, an oral small-molecule GLP-1 receptor agonist.²⁰²¹ They suit people who do not want injections. Their trial results should not be compared with Mounjaro's as if the studies were head to head, because they were not designed that way.

Only SURMOUNT-5 supports a direct comparison of tirzepatide with semaglutide, and a reader should treat any other side-by-side of trial numbers with caution.¹⁵ Different trials enrol different people, run for different lengths and use different methods. A prescriber can discuss the evidence that applies to you.

Our page on a Mounjaro equivalent for weight loss goes further into how these licensed alternatives line up. Whichever you choose, treatment sits alongside a reduced-calorie diet and increased physical activity, and results vary from person to person.

06 · Natural and supplement claims

Natural "GLP-1 equivalents" and supplements: what to know

Supplements sold as natural GLP-1 equivalents are low-cost products with no clinical oversight, and none has been shown to match a prescription medicine. This covers products marketed as "nature's Ozempic", berberine, fibre blends and many capsules stocked on high-street shelves. The marketing often promises dramatic weight-loss claims; the evidence behind licensed medicines does not transfer to these products.

People ask whether a shop such as Holland and Barrett offers GLP-1 supplements. Health shops do sell supplements positioned for appetite or metabolism, but a supplement is not a GLP-1 medicine and is not a licensed treatment for weight management.

The phrase "poor man's Ozempic" is a marketing label, usually attached to berberine. It is a nickname, not a clinical category. Calling something a poor man's version suggests it does the same job at a lower cost, and that is precisely the claim that lacks support. Cheapness, in this case, is a safety and efficacy framing point: low cost often goes hand in hand with no assessment and no follow-up.

There are practical risks worth naming without exaggeration. A supplement can interact with other medicines you take, and with no consultation nobody checks. Labels can be vague. Quality varies between brands. If you take other prescribed medicines, tell a pharmacist or your GP before starting anything new. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive.

If you notice an unexpected symptom after taking any product, speak to a healthcare professional and report it through the MHRA Yellow Card scheme.¹⁹ That applies equally to supplements and to prescription medicines.

None of this means that healthy eating is pointless. Meals built around protein, vegetables and fibre, regular movement and good sleep are sensible for almost everyone, and they are what prescription treatment is meant to support. They simply are not a substitute for the medicine, and they should not be sold as one.

Be especially wary of sellers offering injectable products without a consultation or prescription. Products of that sort may be counterfeit or unlicensed, and the MHRA publishes counterfeit medicine alerts for this reason.⁷ Our guide asking is GLP-1 a con looks at how to tell genuine treatment from hype, and the page on recombinant GLP-1 explains why a lab-made hormone is a different thing from a supplement.

07 · Is Mounjaro a GLP-1 agonist

Is Mounjaro a GLP-1 agonist?

Yes, Mounjaro is a GLP-1 receptor agonist, and it also activates GIP, which makes it a dual-action medicine. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).

So when someone asks for a GLP-1 equivalent to Mounjaro, the answer depends on what they want. If they want another GLP-1 receptor agonist, semaglutide and liraglutide qualify. If they want the same dual mechanism, tirzepatide has no direct equivalent, because it is the first treatment of its kind to activate both GIP and GLP-1 receptors.

What does the evidence for tirzepatide show? In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight. Trial averages do not predict your own result, and they should not be read as a promise.

A worked example makes the percentages concrete. For someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic on the trial average, not a forecast.

Equally, semaglutide has its own evidence base. The STEP 1 trial studied once-weekly semaglutide in adults with overweight or obesity.⁹ SURMOUNT-5 is the trial that compared tirzepatide and semaglutide directly, and your prescriber can talk you through it.¹⁵

If you are weighing tirzepatide, remember it is a prescription-only medicine, supplied after an online consultation reviewed by a GPhC-registered prescriber. Mounjaro (tirzepatide) is used alongside a reduced-calorie diet and increased physical activity.

08 · Cheapest GLP-1 that works

What is the cheapest GLP-1 that works?

Price depends on the product and dose, and a licensed, prescribed medicine is the only kind that has been tested for weight management, unlike any supplement. Low-cost supplements are cheap precisely because they are not medicines, so they are not a fair comparison. For licensed treatment, cost planning means looking at the whole course rather than a single pen.

For Mounjaro, your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Every later order is £25 off the standard price through code DOSE25, applied automatically. Switching to us at a higher dose? A new customer's first order at 15mg is £289.99.

The dose ladder runs from £169.99 at 2.5mg through £218.99 at 5mg, £279.99 at 7.5mg, £290.99 at 10mg and £319.99 at 12.5mg, to £329.99 at 15mg. All are standard prices for a four-week pen. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices; a new customer's first order is £40 less and every later order £25 less.

A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, before discounts. For other maintenance doses, use the monthly price of that dose. Our Mounjaro pen page shows the live figures and the consultation route.

Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider, as checked 10 October 2026. For the starting pen, the range is £143.96 to £179.99. The gap between providers for the same dose runs from £27 to £41, so it is worth comparing like with like.

Wegovy offers another licensed route; its first pen starts at £99.99 as a first-order price. Because the products differ in molecule, dosing and evidence, "cheapest" should not be the only filter.

We offer Klarna and pay-monthly options, with no subscriptions and no hidden fees, and the consultation is free. Repeat orders re-check suitability and there is no auto-shipping, so you stay in control of when you reorder.

09 · NHS and buying online

NHS access and buying GLP-1 medication online

You can buy GLP-1 medication online in the UK, provided it is supplied by a registered pharmacy after a consultation and prescription. Never buy it from a seller who offers to supply without a consultation or prescription. A legitimate pharmacy appears on the GPhC register, and ours is registered under GPhC 9012878.¹²

The NHS is the other route, and it is being phased in. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Wegovy access on the NHS runs through specialist weight-management services; ask your GP. If you are unsure whether you qualify, your GP surgery is the right first conversation, and the NHS guide to tirzepatide explains the basics.⁵

For private supply, here is how our process works. First, you complete a free online consultation, a short health questionnaire with no charge and no obligation. Second, a GPhC-registered prescriber reviews it, not a scoring script; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses and dispatches, with same-day dispatch when you order by 3pm.

Delivery is free next-day tracked service by DPD in temperature-controlled, discreet packaging, and Saturday delivery is £14.99. Needles, a sharps bin and injection guidance come with every order. Our Mounjaro comes by official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.

Counterfeit medicines are a real hazard in this market. The MHRA publishes counterfeit alerts and runs the Yellow Card scheme, where you can report suspected problems or side effects.⁷ Check the pharmacy's registration, expect a proper consultation, and treat unusually easy supply as a warning sign.

If you have questions, our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413. Ongoing monthly reviews, dose titration and follow-up assessments by our prescribing team are included.

10 · Lifestyle alongside treatment

Diet, activity and what you can do without medication

Lifestyle changes are the foundation under every treatment, natural or prescribed. In SURMOUNT-1, people on lifestyle changes alone lost on average 3.1% of body weight, while those taking tirzepatide alongside diet and exercise lost far more, though individual results vary.² Trial averages do not predict your own result. The licensed approach is a reduced-calorie diet and increased physical activity with the medicine, not in place of it.

People often ask how to lose two stones in twelve weeks. A steadier approach is to focus on habits you can keep: regular meals, protein at each one, plenty of vegetables, fewer sugary drinks and more daily movement.

Fibre and protein are sensible ingredients because they help meals feel more filling in the ordinary way. That is a dietary habit, not a GLP-1 equivalent, and it does not replicate the receptor effects of a medicine. Think of it as supporting your own appetite signals rather than overriding them.

Movement does not need to mean a gym. Walking more, taking stairs, and building up gradually all count. If you have a health condition or have been inactive for a long time, check with your GP before beginning anything strenuous.

Sleep and stress matter more than most plans admit. Poor sleep and high stress can make appetite harder to manage, and it is reasonable to treat them as part of the plan. If low mood or disordered eating is part of your picture, speak to your GP, because those deserve proper support rather than a quick fix.

If you do start a prescription medicine, expect to keep these habits going. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, and the free GLPTrackr companion app (iOS and Android) can help you track your journey. Our prescribing team offers side-effect support and monthly reviews to keep you on course.

The point is not to talk anyone out of healthy habits or into medicine. It is to be clear about which tool does what. Habits are for everyone. Medicines are for people who meet the criteria, after proper assessment, and they work best on top of habits rather than as a shortcut around them.

11 · Switching and stopping

Switching between GLP-1 medicines, and stopping

Switching from one GLP-1 medicine to another should be decided with a prescriber, because strengths do not convert neatly between products. A milligram of one medicine is not a milligram of another, and the starting point on a new product depends on your history and how you tolerated the last one.

If you already take another provider's Mounjaro and want to move to us, a new customer's first order at any dose is £40 less with code FIRST40, and every later order is £25 off the standard price. Your prescriber reviews your current dose and suitability before approving.

What if you stop? Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ That four to five weeks is why effects do not stop overnight, and why you should talk to a prescriber rather than guess. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

Storage is straightforward once you know it. Keep unopened pens in the fridge, at 2–8°C, until first use, and they keep until the printed expiry date. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. For anything beyond that, refer to the patient information leaflet and your pharmacy.¹³

Follow the pen's instructions each time, and ask us if anything is unclear. Report any new or worrying symptom to your prescriber and through the Yellow Card scheme.¹⁹ Severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis), pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems), or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing: seek immediate medical help.

For anything else, the safest summary is simple: choose licensed, prescribed treatment, use it with diet and activity, and keep your prescriber informed.